HIGHLIGHTS
- who: Robin Reschke and colleagues from the Department of Dermatology, Allergology and Venereology, University Medical Center, Leipzig, Germany have published the research: Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years), in the Journal: (JOURNAL)
SUMMARY
Melanoma incidence is continuously rising, and patients still die from metastatic disease, despite a portfolio of promising systemic treatment options. A majority of patients with high-risk melanomas develop metastatic disease within the first three years after the diagnosis (65-85%), mostly in the first two years (55-67%). There is still . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.